Form4.ai tracks every SEC insider trade in real time. See every GRCE insider filing with a free account — no card.
See every GRCE insider filing — free account, no card.
Free accountGrace Therapeutics, Inc. (GRCE) has 11 SEC Form 4 insider filings on record in the last 90 days. That includes 9 insider purchases totalling $743K. Most recent filing: Oct. 26, 2026.
Open-market value, last 90 days
Form 4 filings by type, last 90 days
| Date | Insider | Trade | Value | Price since buy |
|---|---|---|---|---|
| Oct 26, 2026 SEC filing | Opaleye Management Inc. 10% Owner | Bought | $158,601 | +0.2% 7D |
| Oct 21, 2026 SEC filing | Opaleye Management Inc. 10% Owner | Bought | $8,001 | -3.7% 7D |
| Oct 16, 2026 SEC filing | Opaleye Management Inc. 10% Owner | Bought | $136,178 | +0.7% 7D |
Create a free account to see all 11 GRCE filings from the last 90 days. No card needed.
Create free accountWant GRCE insider buys the moment they're filed, with Telegram alerts? Try Pro free for 7 days
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.